Clinical Trials Browser

Mesothelioma, Malignant × pembrolizumab × 30 days × Clear all

NCT02959463 2026-05-27

Pembrolizumab After Radiation Therapy in Treating Patients With Pleural Malignant Mesothelioma

Phase 1 Completed

25 enrolled 11 charts

Other solid neoplasmThoracic

Mesothelioma, Malignant

NCT02399371 2026-05-08

Pembrolizumab in Treating Patients With Malignant Mesothelioma

Phase 2 Completed

65 enrolled 12 charts

Other solid neoplasmThoracic

Mesothelioma, Malignant, Solitary Fibrous Tumor, Pleural